The Personal Dilemma of Whole-Body Cancer Screens

Whole-body MRIs and multi-cancer blood tests are investigational for asymptomatic people: they can detect cancers but often cause false positives, unnecessary procedures, and high costs; Busy Philipps’ Prenuvo MRI, which found a malignant brain tumor, underscores how personal risk and privilege shape demand, while experts stress sticking to evidence-based screenings and demanding clear FDA status, costs, and follow-up requirements to avoid widening healthcare inequities.